The linear particle accelerators market size has grown strongly in recent years. It will grow from $2.73 billion in 2025 to $2.9 billion in 2026 at a compound annual growth rate (CAGR) of 5.9%. The growth in the historic period can be attributed to increasing prevalence of cancer worldwide, expansion of radiation oncology infrastructure, rising investments in high-energy physics research, growing adoption of advanced radiotherapy techniques, increased government funding for scientific research facilities.
The linear particle accelerators market size is expected to see strong growth in the next few years. It will grow to $3.53 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to rising demand for advanced cancer treatment technologies, growing focus on precision and targeted radiation therapy, increasing investments in nuclear medicine infrastructure, expanding particle physics research programs, rising healthcare expenditure on oncology services. Major trends in the forecast period include growing adoption of linear accelerators in cancer radiation therapy, increasing use of high-energy linear accelerators in particle physics research, rising demand for precision radiation delivery in oncology treatments, expansion of linear accelerator applications in nuclear medicine, growing deployment of compact and modular linear accelerator systems.
The increasing emphasis on precision medicine is expected to drive the growth of the linear particle accelerators market in the future. Precision medicine involves tailoring medical treatments to individual patients based on their unique characteristics, and its growing prominence is attributed to advancements in genomic research and technology. This approach acknowledges the limitations of traditional healthcare methods and recognizes the potential of personalized treatments for better patient outcomes. Linear particle accelerators play a crucial role in precision medicine by delivering targeted radiation therapy, enabling precise targeting of tumors while minimizing damage to surrounding healthy tissues. For example, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, up from six approvals in 2022. Therefore, the growing focus on precision medicine is driving the growth of the linear particle accelerators market.
Major companies in the linear particle accelerators market are developing innovative solutions, such as AI-powered adaptive computed tomography linear particle accelerators (CT-Linac), to transform cancer treatment. These advanced devices integrate artificial intelligence algorithms with computed tomography technology and particle acceleration capabilities to provide precise, personalized radiation therapy treatments with real-time imaging and adaptive treatment planning. For instance, in May 2024, Elekta launched Elekta Evo, an AI-powered adaptive CT-Linac designed for radiation therapy. This linear particle accelerator offers clinicians unprecedented precision and versatility in cancer treatments, thanks to its next-generation imaging quality and online adaptability capabilities. Elekta Evo utilizes cutting-edge imaging technologies, anatomy-specific algorithms, and potent AI to optimize treatment planning, minimize damage to organs at risk, and reduce uncertainties.
In June 2024, Leo Cancer Care, an Australia-based research firm, formed a partnership with TibaRay to develop a next-generation upright linear accelerator designed to improve photon therapy for cancer treatment. This collaboration combines Leo Cancer Care's innovative upright patient positioning technology with TibaRay's advanced linear accelerator (linac) capabilities. TibaRay is a US-based medical equipment manufacturer specializing in linear particle accelerators.
Major companies operating in the linear particle accelerators market are Elekta AB, Varian Medical Systems, Accuray Incorporated, Siemens Healthineers, Hitachi Ltd., Mitsubishi Electric Corporation, Toshiba Corporation, IBA Group, Mevion Medical Systems, ViewRay Medical Technologies Inc., RefleXion Medical, Panacea Medical Technologies Pvt. Ltd., Shinva Medical Instrument Co. Ltd., Neusoft Medical Systems, Canon Medical Systems, Advanced Oncotherapy, ProTom International, Sumitomo Heavy Industries, Thales Group, Danfysik, Research Instruments GmbH.
North America was the largest region in the linear particle accelerators market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the linear particle accelerators market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the linear particle accelerators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have created cost pressures in the linear particle accelerators market by increasing duties on imported high-precision components, superconducting materials, electronic control systems, and accelerator subassemblies. These impacts have raised manufacturing and installation costs, particularly affecting high-energy and medical linear accelerators, with north america and europe experiencing notable exposure due to reliance on specialized imported components. Research institutions and hospitals have faced higher capital equipment costs, influencing procurement timelines. On the positive side, tariffs have encouraged local manufacturing, supplier diversification, and regional production of accelerator components, supporting long-term supply chain resilience.
The linear particle accelerators market research report is one of a series of new reports that provides linear particle accelerators market statistics, including linear particle accelerators industry global market size, regional shares, competitors with a linear particle accelerators market share, detailed linear particle accelerators market segments, market trends and opportunities, and any further data you may need to thrive in the linear particle accelerators industry. This linear particle accelerators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A linear particle accelerator is a device utilized in particle physics to accelerate charged particles, such as electrons, protons, or ions, to very high speeds. It serves as a fundamental tool in numerous areas of scientific research, including high-energy physics, nuclear physics, and medical radiation therapy.
The primary types of linear particle accelerators include low-energy machines, medium-energy machines, and high-energy machines. Low-energy machines are characterized by energy outputs typically below 10 MeV (mega-electron volts) and are employed for research purposes and industrial applications such as material testing and non-destructive analysis. They are also utilized in various therapies such as radiosurgery and radiation therapy, treating conditions such as prostate cancer, breast cancer, lung cancer, head and neck cancers, colorectal cancers, among others. These machines find applications in various end-user settings including radiology clinics, hospitals, and others.
The linear particle accelerators market consists of sales of accelerating cavities, RF (Radio Frequency) power sources, waveguides and couplers, beam diagnostic instruments, beam control systems, and cooling systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The linear particle accelerators market size is expected to see strong growth in the next few years. It will grow to $3.53 billion in 2030 at a compound annual growth rate (CAGR) of 5.1%. The growth in the forecast period can be attributed to rising demand for advanced cancer treatment technologies, growing focus on precision and targeted radiation therapy, increasing investments in nuclear medicine infrastructure, expanding particle physics research programs, rising healthcare expenditure on oncology services. Major trends in the forecast period include growing adoption of linear accelerators in cancer radiation therapy, increasing use of high-energy linear accelerators in particle physics research, rising demand for precision radiation delivery in oncology treatments, expansion of linear accelerator applications in nuclear medicine, growing deployment of compact and modular linear accelerator systems.
The increasing emphasis on precision medicine is expected to drive the growth of the linear particle accelerators market in the future. Precision medicine involves tailoring medical treatments to individual patients based on their unique characteristics, and its growing prominence is attributed to advancements in genomic research and technology. This approach acknowledges the limitations of traditional healthcare methods and recognizes the potential of personalized treatments for better patient outcomes. Linear particle accelerators play a crucial role in precision medicine by delivering targeted radiation therapy, enabling precise targeting of tumors while minimizing damage to surrounding healthy tissues. For example, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that in 2023, the FDA approved 16 new personalized treatments for patients with rare diseases, up from six approvals in 2022. Therefore, the growing focus on precision medicine is driving the growth of the linear particle accelerators market.
Major companies in the linear particle accelerators market are developing innovative solutions, such as AI-powered adaptive computed tomography linear particle accelerators (CT-Linac), to transform cancer treatment. These advanced devices integrate artificial intelligence algorithms with computed tomography technology and particle acceleration capabilities to provide precise, personalized radiation therapy treatments with real-time imaging and adaptive treatment planning. For instance, in May 2024, Elekta launched Elekta Evo, an AI-powered adaptive CT-Linac designed for radiation therapy. This linear particle accelerator offers clinicians unprecedented precision and versatility in cancer treatments, thanks to its next-generation imaging quality and online adaptability capabilities. Elekta Evo utilizes cutting-edge imaging technologies, anatomy-specific algorithms, and potent AI to optimize treatment planning, minimize damage to organs at risk, and reduce uncertainties.
In June 2024, Leo Cancer Care, an Australia-based research firm, formed a partnership with TibaRay to develop a next-generation upright linear accelerator designed to improve photon therapy for cancer treatment. This collaboration combines Leo Cancer Care's innovative upright patient positioning technology with TibaRay's advanced linear accelerator (linac) capabilities. TibaRay is a US-based medical equipment manufacturer specializing in linear particle accelerators.
Major companies operating in the linear particle accelerators market are Elekta AB, Varian Medical Systems, Accuray Incorporated, Siemens Healthineers, Hitachi Ltd., Mitsubishi Electric Corporation, Toshiba Corporation, IBA Group, Mevion Medical Systems, ViewRay Medical Technologies Inc., RefleXion Medical, Panacea Medical Technologies Pvt. Ltd., Shinva Medical Instrument Co. Ltd., Neusoft Medical Systems, Canon Medical Systems, Advanced Oncotherapy, ProTom International, Sumitomo Heavy Industries, Thales Group, Danfysik, Research Instruments GmbH.
North America was the largest region in the linear particle accelerators market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the linear particle accelerators market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the linear particle accelerators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have created cost pressures in the linear particle accelerators market by increasing duties on imported high-precision components, superconducting materials, electronic control systems, and accelerator subassemblies. These impacts have raised manufacturing and installation costs, particularly affecting high-energy and medical linear accelerators, with north america and europe experiencing notable exposure due to reliance on specialized imported components. Research institutions and hospitals have faced higher capital equipment costs, influencing procurement timelines. On the positive side, tariffs have encouraged local manufacturing, supplier diversification, and regional production of accelerator components, supporting long-term supply chain resilience.
The linear particle accelerators market research report is one of a series of new reports that provides linear particle accelerators market statistics, including linear particle accelerators industry global market size, regional shares, competitors with a linear particle accelerators market share, detailed linear particle accelerators market segments, market trends and opportunities, and any further data you may need to thrive in the linear particle accelerators industry. This linear particle accelerators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
A linear particle accelerator is a device utilized in particle physics to accelerate charged particles, such as electrons, protons, or ions, to very high speeds. It serves as a fundamental tool in numerous areas of scientific research, including high-energy physics, nuclear physics, and medical radiation therapy.
The primary types of linear particle accelerators include low-energy machines, medium-energy machines, and high-energy machines. Low-energy machines are characterized by energy outputs typically below 10 MeV (mega-electron volts) and are employed for research purposes and industrial applications such as material testing and non-destructive analysis. They are also utilized in various therapies such as radiosurgery and radiation therapy, treating conditions such as prostate cancer, breast cancer, lung cancer, head and neck cancers, colorectal cancers, among others. These machines find applications in various end-user settings including radiology clinics, hospitals, and others.
The linear particle accelerators market consists of sales of accelerating cavities, RF (Radio Frequency) power sources, waveguides and couplers, beam diagnostic instruments, beam control systems, and cooling systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Linear Particle Accelerators Market Characteristics
3. Linear Particle Accelerators Market Supply Chain Analysis
4. Global Linear Particle Accelerators Market Trends and Strategies
5. Linear Particle Accelerators Market Analysis of End Use Industries
7. Global Linear Particle Accelerators Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Linear Particle Accelerators Total Addressable Market (TAM) Analysis for the Market
9. Linear Particle Accelerators Market Segmentation
10. Linear Particle Accelerators Market Regional and Country Analysis
11. Asia-Pacific Linear Particle Accelerators Market
12. China Linear Particle Accelerators Market
13. India Linear Particle Accelerators Market
14. Japan Linear Particle Accelerators Market
15. Australia Linear Particle Accelerators Market
16. Indonesia Linear Particle Accelerators Market
17. South Korea Linear Particle Accelerators Market
18. Taiwan Linear Particle Accelerators Market
19. South East Asia Linear Particle Accelerators Market
20. Western Europe Linear Particle Accelerators Market
21. UK Linear Particle Accelerators Market
22. Germany Linear Particle Accelerators Market
23. France Linear Particle Accelerators Market
24. Italy Linear Particle Accelerators Market
25. Spain Linear Particle Accelerators Market
26. Eastern Europe Linear Particle Accelerators Market
27. Russia Linear Particle Accelerators Market
28. North America Linear Particle Accelerators Market
29. USA Linear Particle Accelerators Market
30. Canada Linear Particle Accelerators Market
31. South America Linear Particle Accelerators Market
32. Brazil Linear Particle Accelerators Market
33. Middle East Linear Particle Accelerators Market
34. Africa Linear Particle Accelerators Market
36. Linear Particle Accelerators Market Competitive Landscape and Company Profiles
37. Linear Particle Accelerators Market Other Major and Innovative Companies
40. Linear Particle Accelerators Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Linear Particle Accelerators Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses linear particle accelerators market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for linear particle accelerators? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The linear particle accelerators market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: Low-energy Machine; Medium-energy Machine; High-energy Machine2) By Therapy: Radio Surgery; Radiation Therapy
3) By Applications: Prostate Cancer; Breast Cancer; Lung Cancer; Head and Neck Cancers; Colorectal Cancers; Other Applications
4) By End User: Radiology Clinics; Hospitals; Other End Users
Subsegments:
1) By Low-Energy Machine: Medical Linacs (Linear Accelerators For Radiation Therapy); Research Linacs2) By Medium-Energy Machine: Industrial Linear Accelerators; Medical Linear Accelerators for Conventional Radiotherapy
3) By High-Energy Machine: High-Energy Research Linear Accelerators; Proton and Heavy-Ion Linear Accelerators
Companies Mentioned: Elekta AB; Varian Medical Systems; Accuray Incorporated; Siemens Healthineers; Hitachi Ltd.; Mitsubishi Electric Corporation; Toshiba Corporation; IBA Group; Mevion Medical Systems; ViewRay Medical Technologies Inc.; RefleXion Medical; Panacea Medical Technologies Pvt. Ltd.; Shinva Medical Instrument Co. Ltd.; Neusoft Medical Systems; Canon Medical Systems; Advanced Oncotherapy; ProTom International; Sumitomo Heavy Industries; Thales Group; Danfysik; Research Instruments GmbH
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Linear Particle Accelerators market report include:- Elekta AB
- Varian Medical Systems
- Accuray Incorporated
- Siemens Healthineers
- Hitachi Ltd.
- Mitsubishi Electric Corporation
- Toshiba Corporation
- IBA Group
- Mevion Medical Systems
- ViewRay Medical Technologies Inc.
- RefleXion Medical
- Panacea Medical Technologies Pvt. Ltd.
- Shinva Medical Instrument Co. Ltd.
- Neusoft Medical Systems
- Canon Medical Systems
- Advanced Oncotherapy
- ProTom International
- Sumitomo Heavy Industries
- Thales Group
- Danfysik
- Research Instruments GmbH
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.9 Billion |
| Forecasted Market Value ( USD | $ 3.53 Billion |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
